The effect of bromocriptine-rebound method on ongoing pregnancy and live birth after intracytoplasmic sperm injection cycles: a randomized clinical trial

Ashraf   Alleyassin; Ramak  Esmailizad; Marzieh   Agha-Hosseini; Leila   Safdarian; Fatemeh   Sarvi; Abas   Kokab

Annals of Military and Health Sciences Research

Current Issue All Issues In Press Accepted Manuscripts Search

Journal Information Editors and Boards Indexing and Listing Sources Reviewer and AE Registration Form Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support

Authors Guide Submit Manuscript

The effect of bromocriptine-rebound method on ongoing pregnancy and live birth after intracytoplasmic sperm injection cycles: a randomized clinical trial

Author(s):

Ashraf Alleyassin¹,

Ramak Esmailizad ²,

Marzieh Agha-Hosseini¹,

Leila Safdarian¹,

Fatemeh Sarvi^1,*,

Abas Kokab ²

1Department of Infertility, Tehran University of Medical Sciences, Tehran, Iran, Andorra

2Department of Infertility, Tehran University of Medical Sciences, Tehran, Iran., Andorra

Annals of Military and Health Sciences Research:Vol. 12, issue 3; e63508

Published online:Oct 29, 2014

Article type:Research Article

Received:Jun 17, 2014

Accepted:Aug 28, 2014

How to Cite:Ashraf AlleyassinRamak Esmailizad Marzieh Agha-HosseiniLeila SafdarianFatemeh SarviAbas Kokab et al.The effect of bromocriptine-rebound method on ongoing pregnancy and live birth after intracytoplasmic sperm injection cycles: a randomized clinical trial.Ann Mil Health Sci Res.12(3):e63508.

Abstract

Materials and Methods: A total of 114 women underwent ICSI. Pregnancy outcomes and hormonal data were compared between two groups, i.e. long protocol and BRM. Ovulatory women with normal serum prolactin levels were assigned to either BRM (n = 57 cycles) or long protocol (n = 57 cycles). Both procedures were carried out in a similar way. However, a group of patients were given bromocriptine daily from the 4th day of the preceding cycle until 7 days before gonadotropin stimulation.

Results: There were no significant differences in the numbers of developed follicles,total retrieval oocytes, transferredembryo and embryos with superior morphology between the two groups. Also, the values of chemical, clinical and ongoing pregnancies and live births were not significantly different (36.8%, 35.1%, 28.1%, 28.1% in BRM group and 43.9%, 38.6%, 21.1% and 19.3% in long protocol, respectively). Ongoing pregnancy and live birth were significantly higher in chemical pregnancy in the BRM group (P = .04 and P = .035, respectively).

Conclusion: This prospective study demonstrated that BRM might lead to higher ongoing pregnancy and live birth rates compared to the long protocol in women undergoing intracytoplasmic sperm injection cycles.

Keywords

bromocriptine

intracytoplasmic sperm injection

live birth

prolactin

Iran

Fulltext

Full text is available in PDF.

References

1.
references is available in PDF.

comments